A new and unexpected role is identified for Srebps in controlling NK cell activity that is independent of their role in lipid biosynthesis.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pearce, E.L., Poffenberger, M.C., Chang, C.H. & Jones, R.G. Science 342, 1242454 (2013).
Kidani, Y. et al. Nat. Immunol. 14, 489–499 (2013).
Shimano, H. & Sato, R. Nat. Rev. Endocrinol. http://dx.doi.org/10.1038/nrendo.2017.91 (29 August 2017).
Assmann, N. et al. Nat. Immunol. 18, 1197–1206 (2017).
Vivier, E. et al. Science 331, 44–49 (2011).
Guillerey, C., Huntington, N.D. & Smyth, M.J. Nat. Immunol. 17, 1025–1036 (2016).
Donnelly, R.P. et al. J. Immunol. 193, 4477–4484 (2014).
Marçais, A. et al. Nat. Immunol. 15, 749–757 (2014).
Chang, S. & Aune, T.M. Proc. Natl. Acad. Sci. USA 102, 17095–17100 (2005).
Gardiner, C.M. & Finlay, D.K. Front. Immunol. 8, 367 (2017).
York, A.G. & Bensinger, S.J. J. Exp. Med. 210, 1653–1656 (2013).
Gold, E.S. et al. Proc. Natl. Acad. Sci. USA 111, 10666–10671 (2014).
Viel, S. et al. Sci. Signal. 9, ra19 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.J.S. has research agreements with Bristol Myers Squibb, Tizona Therapeutics, Corvus Pharmaceuticals and Aduro Biotech.
Rights and permissions
About this article
Cite this article
Guillerey, C., Smyth, M. Cytokine-driven role of Srebps in killer cell metabolism. Nat Immunol 18, 1183–1184 (2017). https://doi.org/10.1038/ni.3855
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3855